BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16964563)

  • 21. Chronic caffeine treatment attenuates experimental autoimmune encephalomyelitis induced by guinea pig spinal cord homogenates in Wistar rats.
    Chen GQ; Chen YY; Wang XS; Wu SZ; Yang HM; Xu HQ; He JC; Wang XT; Chen JF; Zheng RY
    Brain Res; 2010 Jan; 1309():116-25. PubMed ID: 19879252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An aza-anthrapyrazole negatively regulates Th1 activity and suppresses experimental autoimmune encephalomyelitis.
    Clark MP; Leaman DW; Hazelhurst LA; Hwang ES; Quinn A
    Int Immunopharmacol; 2016 Feb; 31():74-87. PubMed ID: 26709219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peroxisome proliferator-activated receptor delta limits the expansion of pathogenic Th cells during central nervous system autoimmunity.
    Dunn SE; Bhat R; Straus DS; Sobel RA; Axtell R; Johnson A; Nguyen K; Mukundan L; Moshkova M; Dugas JC; Chawla A; Steinman L
    J Exp Med; 2010 Aug; 207(8):1599-608. PubMed ID: 20624891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
    Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
    Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses.
    Tan YV; Abad C; Wang Y; Lopez R; Waschek J
    Brain Behav Immun; 2015 Feb; 44():167-175. PubMed ID: 25305591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PPARgamma antagonists reverse the inhibition of neural antigen-specific Th1 response and experimental allergic encephalomyelitis by Ciglitazone and 15-deoxy-Delta12,14-prostaglandin J2.
    Raikwar HP; Muthian G; Rajasingh J; Johnson CN; Bright JJ
    J Neuroimmunol; 2006 Sep; 178(1-2):76-86. PubMed ID: 16844232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An MHC anchor-substituted analog of myelin oligodendrocyte glycoprotein 35-55 induces IFN-gamma and autoantibodies in the absence of experimental autoimmune encephalomyelitis and optic neuritis.
    Ford ML; Evavold BD
    Eur J Immunol; 2004 Feb; 34(2):388-97. PubMed ID: 14768043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential targets of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor for multiple sclerosis therapy.
    Nath N; Giri S; Prasad R; Singh AK; Singh I
    J Immunol; 2004 Jan; 172(2):1273-86. PubMed ID: 14707106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-33 blockade suppresses the development of experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Li M; Li Y; Liu X; Gao X; Wang Y
    J Neuroimmunol; 2012 Jun; 247(1-2):25-31. PubMed ID: 22516472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. α-Synuclein deficiency promotes neuroinflammation by increasing Th1 cell-mediated immune responses.
    Ettle B; Kuhbandner K; Jörg S; Hoffmann A; Winkler J; Linker RA
    J Neuroinflammation; 2016 Aug; 13(1):201. PubMed ID: 27565429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble egg antigen from Schistosoma japonicum modulates the progression of chronic progressive experimental autoimmune encephalomyelitis via Th2-shift response.
    Zheng X; Hu X; Zhou G; Lu Z; Qiu W; Bao J; Dai Y
    J Neuroimmunol; 2008 Feb; 194(1-2):107-14. PubMed ID: 18207251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.
    Choi JH; Lee MJ; Jang M; Kim EJ; Shim I; Kim HJ; Lee S; Lee SW; Kim YO; Cho IH
    PLoS One; 2015; 10(10):e0138592. PubMed ID: 26444423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation.
    Guo W; Wang C; Wang X; Luo C; Yu D; Wang Y; Chen Y; Lei W; Gao X; Yao W
    Oncotarget; 2015 Oct; 6(30):28539-55. PubMed ID: 26384304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vasoactive intestinal peptide loss leads to impaired CNS parenchymal T-cell infiltration and resistance to experimental autoimmune encephalomyelitis.
    Abad C; Tan YV; Lopez R; Nobuta H; Dong H; Phan P; Feng JM; Campagnoni AT; Waschek JA
    Proc Natl Acad Sci U S A; 2010 Nov; 107(45):19555-60. PubMed ID: 20978211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective effects of catalpol and rhein in murine experimental autoimmune encephalomyelitis via regulation of T helper (Th) 1, Th2, Th17, and regulatory T cell responses.
    Wei M; Yang T; Li Q; Zhou D; Du Z; Fan Y
    J Tradit Chin Med; 2019 Dec; 39(6):809-817. PubMed ID: 32186151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of Th2 response in IL-6-deficient mice immunized with myelin oligodendrocyte glycoprotein.
    Okuda Y; Sakoda S; Saeki Y; Kishimoto T; Yanagihara T
    J Neuroimmunol; 2000 Jun; 105(2):120-3. PubMed ID: 10742553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein kinase Ctheta controls Th1 cells in experimental autoimmune encephalomyelitis.
    Salek-Ardakani S; So T; Halteman BS; Altman A; Croft M
    J Immunol; 2005 Dec; 175(11):7635-41. PubMed ID: 16301673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of resistance to active experimental allergic encephalomyelitis by myelin basic protein-specific Th2 cell lines generated in the presence of glucocorticoids and IL-4.
    Ramírez F; Mason D
    Eur J Immunol; 2000 Mar; 30(3):747-58. PubMed ID: 10741389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel disease-modifying anti-rheumatic drug iguratimod suppresses chronic experimental autoimmune encephalomyelitis by down-regulating activation of macrophages/microglia through an NF-κB pathway.
    Li G; Yamasaki R; Fang M; Masaki K; Ochi H; Matsushita T; Kira JI
    Sci Rep; 2018 Jan; 8(1):1933. PubMed ID: 29386552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of an autoimmune model for multiple sclerosis in Th2-biased GATA3 transgenic mice.
    Fernando V; Omura S; Sato F; Kawai E; Martinez NE; Elliott SF; Yoh K; Takahashi S; Tsunoda I
    Int J Mol Sci; 2014 Jan; 15(2):1700-18. PubMed ID: 24463292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.